3 Result(s)

Article

Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenoty**

Alain Ndayisaba, Ariana T. Pitaro, Andrew S. Willett, Kristie A. Jones… in The Cerebellum (2024)

Article

Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenoty**

Multiple system atrophy (MSA) is a fatal neurodegenerative disease of unknown etiology characterized by widespread aggregation of the protein alpha-synuclein in neurons and glia. Its orphan status, biological ...

Alain Ndayisaba, Ariana T. Pitaro, Andrew S. Willett, Kristie A. Jones… in The Cerebellum (2024)

Article

Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects

Differentiating multiple system atrophy (MSA) from related neurodegenerative movement disorders (NMD) is challenging. MRI is widely available and automated decision-tree analysis is simple, transparent, and re...

Jisoo Kim, Geoffrey S. Young, Andrew S. Willett, Ariana T. Pitaro… in The Cerebellum (2023)